BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossello X, Yellon DM. A critical review on the translational journey of cardioprotective therapies! International Journal of Cardiology 2016;220:176-84. [DOI: 10.1016/j.ijcard.2016.06.131] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Rossello X, Yellon DM. The RISK pathway and beyond. Basic Res Cardiol 2018;113:2. [PMID: 29143177 DOI: 10.1007/s00395-017-0662-x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 94] [Article Influence: 18.6] [Reference Citation Analysis]
2 Rossello X, Rodriguez-Sinovas A, Vilahur G, Crisóstomo V, Jorge I, Zaragoza C, Zamorano JL, Bermejo J, Ordoñez A, Boscá L, Vázquez J, Badimón L, Sánchez-Margallo FM, Fernández-Avilés F, Garcia-Dorado D, Ibanez B. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions. Sci Rep 2019;9:20290. [PMID: 31889088 DOI: 10.1038/s41598-019-56613-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
3 Rossello X, Lobo-Gonzalez M, Ibanez B. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome. Eur Heart J Acute Cardiovasc Care 2019;8:443-56. [PMID: 31172789 DOI: 10.1177/2048872619845283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
4 Rossello X, Yellon DM. A new era in the management of type 2 diabetes: Is cardioprotection at long last a reality? International Journal of Cardiology 2017;228:198-200. [DOI: 10.1016/j.ijcard.2016.11.246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lee SR, Nilius B, Han J. Gaseous Signaling Molecules in Cardiovascular Function: From Mechanisms to Clinical Translation. Rev Physiol Biochem Pharmacol 2018;174:81-156. [PMID: 29372329 DOI: 10.1007/112_2017_7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
6 Yellon DM, Rossello X. Xenon: A Noble Member of the Cardioprotection Club. J Am Coll Cardiol 2017;70:2661-2. [PMID: 29169473 DOI: 10.1016/j.jacc.2017.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Xiao Y, Song C, Lin Q, Shi X, Yu W, Huang X, Wang H, Chen Y, Wang R, Geng X, Qin M, Hu K, Fan Y, Qiao Y, Gao E, Zhao W, Chang J. Cardioprotection of (±)-sodium 5-bromo-2-(α-hydroxypentyl) benzoate (BZP) on mouse myocardium I/R injury through inhibiting 12/15-LOX-2 activity. Journal of Molecular and Cellular Cardiology 2019;135:52-66. [DOI: 10.1016/j.yjmcc.2019.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Dyson A, Dal-Pizzol F, Sabbatini G, Lach AB, Galfo F, Dos Santos Cardoso J, Pescador Mendonça B, Hargreaves I, Bollen Pinto B, Bromage DI, Martin JF, Moore KP, Feelisch M, Singer M. Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models. PLoS Med 2017;14:e1002310. [PMID: 28678794 DOI: 10.1371/journal.pmed.1002310] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
9 Yang Z, Shao Q, Ge Z, Ai N, Zhao X, Fan X. A Bioactive Chemical Markers Based Strategy for Quality Assessment of Botanical Drugs: Xuesaitong Injection as a Case Study. Sci Rep 2017;7:2410. [PMID: 28546540 DOI: 10.1038/s41598-017-02305-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
10 Lorca R, Jiménez-blanco M, García-ruiz JM, Pizarro G, Fernández-jiménez R, García-álvarez A, Fernández-friera L, Lobo-gonzález M, Fuster V, Rossello X, Ibáñez B. Coexistencia de progresión transmural y lateral del frente de onda en el infarto de miocardio humano. Revista Española de Cardiología 2021;74:870-7. [DOI: 10.1016/j.recesp.2020.07.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chen T, Vunjak-Novakovic G. In vitro Models of Ischemia-Reperfusion Injury. Regen Eng Transl Med 2018;4:142-53. [PMID: 30393757 DOI: 10.1007/s40883-018-0056-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
12 Ibanez B, Rossello X. Left Ventricular Remodeling Is No Longer a Relevant Outcome After Myocardial Infarction. JACC: Cardiovascular Imaging 2019;12:2457-9. [DOI: 10.1016/j.jcmg.2019.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Farine E, Niederberger P, Wyss RK, Méndez-Carmona N, Gahl B, Fiedler GM, Carrel TP, Tevaearai Stahel HT, Longnus SL. Controlled Reperfusion Strategies Improve Cardiac Hemodynamic Recovery after Warm Global Ischemia in an Isolated, Working Rat Heart Model of Donation after Circulatory Death (DCD). Front Physiol 2016;7:543. [PMID: 27920725 DOI: 10.3389/fphys.2016.00543] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
14 Glembotski CC, Rosarda JD, Wiseman RL. Proteostasis and Beyond: ATF6 in Ischemic Disease. Trends Mol Med 2019;25:538-50. [PMID: 31078432 DOI: 10.1016/j.molmed.2019.03.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
15 van der Weg K, Kuijt WJ, Bekkers SC, Tijssen JG, Green CL, Smulders MW, Lemmert ME, Krucoff MW, Gorgels AP. Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury. International Journal of Cardiology 2018;271:240-6. [DOI: 10.1016/j.ijcard.2018.05.083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
16 Lorca R, Jiménez-Blanco M, García-Ruiz JM, Pizarro G, Fernández-Jiménez R, García-Álvarez A, Fernández-Friera L, Lobo-González M, Fuster V, Rossello X, Ibáñez B. Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart. Rev Esp Cardiol (Engl Ed) 2021;74:870-7. [PMID: 32855096 DOI: 10.1016/j.rec.2020.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yu Z, Wen Y, Jiang N, Li Z, Guan J, Zhang Y, Deng C, Zhao L, Zheng SG, Zhu Y, Su W, Zhuo Y. TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis. Biomaterials 2022;284:121484. [DOI: 10.1016/j.biomaterials.2022.121484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yi T, Wu X, Li H. Ubiquinol-cytochrome c reductase core protein 1 overexpression protects H9c2 cardiac cells against mimic ischemia/reperfusion injury through PI3K/Akt/GSK-3β pathway. Biochem Biophys Res Commun 2020;529:904-9. [PMID: 32819597 DOI: 10.1016/j.bbrc.2020.06.089] [Reference Citation Analysis]
19 Rogers RG, Otis JS. Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype. Cardiovasc Drugs Ther 2017;31:29-38. [PMID: 28064408 DOI: 10.1007/s10557-016-6707-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
20 Su X, Zhou M, Li Y, Zhang J, An N, Yang F, Zhang G, Yuan C, Chen H, Wu H, Xing Y. Protective effects of natural products against myocardial ischemia/reperfusion: Mitochondria-targeted therapeutics. Biomed Pharmacother 2022;149:112893. [PMID: 35366532 DOI: 10.1016/j.biopha.2022.112893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Karwi QG, Bice JS, Baxter GF. Pre- and postconditioning the heart with hydrogen sulfide (H2S) against ischemia/reperfusion injury in vivo: a systematic review and meta-analysis. Basic Res Cardiol 2018;113:6. [PMID: 29242986 DOI: 10.1007/s00395-017-0664-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
22 Hall AB, Brilakis ES. Remote Ischemic Preconditioning for Percutaneous Coronary Intervention: Waiting for Godot? J Am Heart Assoc 2018;7:e010755. [PMID: 30371313 DOI: 10.1161/JAHA.118.010755] [Reference Citation Analysis]
23 Zaugg M, Lou PH, Lucchinetti E, Gandhi M, Clanachan AS. Postconditioning with Intralipid emulsion protects against reperfusion injury in post-infarct remodeled rat hearts by activation of ROS-Akt/Erk signaling. Transl Res 2017;186:36-51.e2. [PMID: 28641075 DOI: 10.1016/j.trsl.2017.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Datta T, Przyklenk K, Datta NS. Parathyroid Hormone-Related Peptide: A Novel Endocrine Cardioprotective "Conditioning Mimetic". J Cardiovasc Pharmacol Ther 2017;22:529-37. [PMID: 28403647 DOI: 10.1177/1074248417702976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Rossello X, He Z, Yellon DM. Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute. Cardiovasc Drugs Ther 2018;32:127-33. [PMID: 29656359 DOI: 10.1007/s10557-018-6788-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
26 Cheng X, Li H, Yan Z, Liu J, Hu Z. Ischemic limb preconditioning-induced anti-arrhythmic effect in reperfusion-induced myocardial injury: is it mediated by the RISK or SAFE pathway? Pflugers Arch 2022. [PMID: 35695933 DOI: 10.1007/s00424-022-02716-5] [Reference Citation Analysis]